Skip to main content
Fig. 9 | Cancer Cell International

Fig. 9

From: Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalities

Fig. 9

Assessment of lung cancer and lymph node characteristics during treatment of the case. (A) Changes in lung cancer tumor diameter. (B) White blood cell (WBC) count dynamics. (C) Lymph node count variation. (D) Maximal lymph node diameter changes. (E) SPD of measured lymph nodes, SPD represents the sum of the products of the perpendicular diameters of measured lymph nodes

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us